Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

Trullàs, Joan Carles; Mocroft, Amanda; Cofan, Frederic; Tourret, Jérôme; Moreno, Asunción; Bagnis, Corinne Isnard; Fux, Christoph A; Katlama, Christine; Reiss, Peter; Lundgren, Jens D.; Gatell, José M.; Kirk, Ole; Miró, José M.

doi:10.1097/qai.0b013e3181efbe59

Cited by 42 publications

(45 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This has been correlated with higher mortality. [12,[22][23][24] Reasons for incomplete HIV viral suppression have been ascribed to inexperience with HIV treatment and poor prescribing practices by nephrologists, with both under-and over-prescription of ART, and infrequent consultation and follow-up with an infectious diseases specialist. [24] These factors must be considered as possible explanations in this study, as many nephrologists initiate and continue ART without input from an infectious diseases specialist in the medically insured setting.…”

Section: Discussionmentioning

confidence: 99%

Morbidity and mortality of black HIV-positive patients with end-stage kidney disease receiving chronic haemodialysis in South Africa

Fabian

Maher

Clark³

et al. 2015

S Afr Med J

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Morbidity and mortality of black HIV-positive patients with end-stage kidney disease receiving chronic haemodialysis in South Africa

Fabian

Maher

Clark³

et al. 2015

S Afr Med J

View full text Add to dashboard Cite

“…Earlier studies, mainly from the USA, concluded that, almost exclusively in Black patients, HIVAN is one of the major causes of ESRD [6,21,22], but histological confirmation of HIVAN is infrequent and the diagnosis is usually made clinically. More recent studies have reported an increasing relevance of traditional risk factors as well as chronic hepatitis C virus (HCV) coinfection in the development of ESRD in HIVinfected patients [7,23].The epidemiology of ESRD outside the USA has not been extensively studied [24][25][26][27] but could provide new insights, as most US cohorts consist of a high proportion of Black patients with coeval injecting drug use (IVDU). Conversely, European cohorts consist of mostly Caucasian HIVinfected patients with various proportions of IDU and far fewer Black patients with almost no IDU [19,26,28].…”

mentioning

confidence: 99%

End‐stage renal disease and dialysis in HIV‐positive patients: observations from a long‐term cohort study with a follow‐up of 22 years

et al. 2012

View full text Add to dashboard Cite

ObjectivesRenal disease is a common and serious complication in HIV-infected patients. MethodsA retrospective cohort analysis for the period 1989-2010 was carried out to determine the prevalence, incidence and risk factors for end-stage renal disease (ESRD). ESRD was defined as initiation of renal replacement therapy. Three time periods were defined: 1989-1996 [pre-highly active antiretroviral therapy (HAART)], 1997 (early HAART) and 2004. ResultsData for 9198 patients [78.2% male; 88.9% Caucasian; cumulative observation time 68 084 patient-years (PY)] were analysed. ESRD was newly diagnosed in 35 patients (0.38%). Risk factors for ESRD were Black ethnicity [relative risk (RR) 5.1; 95% confidence interval (CI) 2.3-10.3; P < 0.0001], injecting drug use (IDU) (RR 2.3; 95% CI 1.1-4.6; P = 0.02) and hepatitis C virus (HCV) coinfection (RR 2.2; 95% CI 1.1-4.2; P = 0.03). The incidence of ESRD decreased in Black patients over the three time periods [from 788.8 to 130.5 and 164.1 per 100 000 PY of follow-up (PYFU), respectively], but increased in Caucasian patients (from 29.9 to 41.0 and 43.4 per 100 000 PYFU, respectively). The prevalence of ESRD increased over time and reached 1.9 per 1000 patients in 2010. Mortality for patients with ESRD decreased nonsignificantly from period 1 to 2 (RR 0.72; P = 0.52), but significantly from period 1 to 3 (RR 0.24; P = 0.006), whereas for patients without ESRD mortality decreased significantly for all comparisons. ESRD was associated with a high overall mortality (RR 9.9; 95% CI 6.3-14.5; P < 0.0001). ConclusionAs a result of longer survival, the prevalence of ESRD is increasing but remains associated with a high mortality. The incidence of ESRD declined in Black but not in Caucasian patients. IDU and HCV were identified as additional risk factors for the development of ESRD.Keywords: chronic kidney disease, haemodialysis, HIV-associated nephropathy, renal failure, renal replacement therapy Accepted 18 July 2012 IntroductionThe prevention and treatment of cardiovascular, liver and kidney diseases have increasingly been the focus of attention in attempts to reduce the morbidity and mortality of HIV-infected individuals [1]. In the USA, HIV-associated ESRD has become epidemic among Black patients [11,12]. Black individuals are more prone to kidney disease than any other ethnic group in the general [13,14] and HIV-infected populations, possibly as a consequence of predisposing genetic polymorphisms [15]. The risk of ESRD in Black HIV-infected individuals has been reported to be three-to six-fold higher than in Caucasian HIV-infected patients [7,16,17], reflecting the susceptibility of Black patients to develop HIVAN. The introduction of highly active antiretroviral therapy (HAART) has reduced the incidence of HIVAN and ESRD among Black patients [18][19][20], but the prevalence of ESRD is projected to further increase [11,12]. Earlier studies, mainly from the USA, concluded that, almost exclusively in Black patients, HIVAN is one of the major causes of ESRD [6,21,22], but histologica...

show abstract

“…In the aforementioned EuroSIDA survey, out of 122 patients with ESRD, 96 received dialysis and 26 renal transplant. The most frequent causes of ESRD were HIV-associated nephropathy and other glomerulonephritis [10]. The advantages and disadvantages of each form of dialysis in HIV-infected patients are presented in Table 1.…”

Section: Methods For Treating Chronic Renal Failure In Hiv-infected Pmentioning

confidence: 99%

“…In a cross-sectional multicenter EuroSIDA survey, the prevalence of end-stage renal disease (ESRD) was 0.5% [10], and an observational cohort study conducted in Great Britain showed a 3.8-fold increase in ESRD among the black HIV-positive patients in the cohort during the 12-year study period [11]. The percentage of patients infected with HIV in dialysis centers around the world ranges from 0.3% to as high as 38% [12].…”

Section: Epidemiology Of Renal Failure In Persons Infected With Hivmentioning

confidence: 99%

Croatian Recommendations for Dialysis of HIV-Positive Patients

et al. 2016

View full text Add to dashboard Cite

show abstract

Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

Abstract: This is the first multinational cross-sectional study of ESRD among European HIV population. Low prevalence of ESRD was found. Two-thirds of patients were excluded from RT for non-HIV/AIDS-related pathologies. Most patients had a functioning graft despite a high acute rejection rate.

Cited by 42 publications

References 26 publications

Morbidity and mortality of black HIV-positive patients with end-stage kidney disease receiving chronic haemodialysis in South Africa

Morbidity and mortality of black HIV-positive patients with end-stage kidney disease receiving chronic haemodialysis in South Africa

End‐stage renal disease and dialysis in HIV‐positive patients: observations from a long‐term cohort study with a follow‐up of 22 years

Croatian Recommendations for Dialysis of HIV-Positive Patients

Contact Info

Product

Resources

About